An amendment numbered 1 printed in Part A of House Report 119-130 to require all HHS regulations or guidance documentation to use language that is inclusive of all opioid overdose reversal drugs that have been approved by FDA, instead of referring to brand names.

passedUnited States· United States Congress· EN

Introduced

—

Last action

—

Status

On agreeing to the Bresnahan amendment (A001) Agreed to by voice vote.

Records

Official amendment HAMDT 23 (119th) from United States at United States Congress. Status: On agreeing to the Bresnahan amendment (A001) Agreed to by voice vote..

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

No documents linked.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Vertaal naar

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Related records

amends → SUPPORT for Patients and Communities Reauthorization Act of 2025

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.

Official source: https://www.congress.gov/amendment/119th-congress/hamdt-23
Open data entity: https://api.congress.gov/v3/amendment/119/hamdt/23
us · 119-hamdt-23 · source updated 5 June 2025